A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers.
Nicolas AideLaurent PoulainNicolas ElieMélanie BriandFlorence GiffardCécile Blanc-FournierFlorence JolyCharline LasnonPublished in: EJNMMI research (2021)
The present work demonstrates that PSMA expression is negligible and a fortiori non-sufficient to ensure its usefulness as a prognosticator or a target for a theranostic strategy in ovarian cancers.